Patents Assigned to Cadila Corporated Campus
  • Publication number: 20140045771
    Abstract: The present invention is directed to novel compounds of formula I and pharmaceutically acceptable salts, enantiomers thereof having inhibiting properties of dipeptidyl peptidase IV enzyme (DP-IV inhibitors). The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds along with its composition in the prevention or treatment of diseases associated with DP-IV enzyme.
    Type: Application
    Filed: October 21, 2013
    Publication date: February 13, 2014
    Applicant: Cadila Corporated Campus
    Inventors: Bakulesh Mafatlal Khamar, Singh Chandan, Rajiv Indravadan Modi